I have written many times about CVTX, a small biotech specializing in cardiac drugs.
I have beleived that the stock was undervalued for some time.
Now Astellas has shown they agree.
Posted on January 27, 2009 by
pharmaking
Articles by tag - cvtx
The AHA is coming up this weekend. There are a few good trades I see going in to the meeting.
These are stocks I have talked about before, but there are good new reasons to looks at them
Posted on November 07, 2008 by
pharmaking
CVTX just sold half of the rights to their new stress testing drug for a price that shows just how undervalued their stock is.
Posted on April 16, 2008 by
pharmaking
Here is how I anticipate the big trials out of the AHA panning out and how you can trade based on these projected results
Posted on November 04, 2007 by
pharmaking
As I surveyed the carnage from last weekâs market drop, I tried to focus on those stocks that actually moved up. Of these, the most interesting to me are CVTX, BSX, and ISRG. I have written about the first two before, so I will be brief here.
Posted on October 21, 2007 by
pharmaking
Ranexa- CVTX's lead drug has sold poorly- hampered by a difficult label. The company just submitted an application to change that label- which will almost certainly be accepted- and the stock traded down. With the diabetes data likely to come out soon, this is a great time to start or add to a position in CVTX.
Posted on October 01, 2007 by
pharmaking
